Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Supriya Lifescience: Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
News Announcement

Supriya Lifescience: Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

10-Aug-2024 Follow Value Research Online on Google download pdfDownload PDF Supriya Lifescience

Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please be informed that the Board of Directors of the Company at its Meeting held on Saturday August 10 2024 inter-alia has 1. Considered and approved the Unaudited Financial Results for the Quarter ended June 30 2024 2. Approved the additional Capital Expenditure at Ambernath site for CDMO facility.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month